Clinical Trial Update: Lenalidomide/Low-dose Dexamethasone in Combination With Continuous Oral Cyclophosphamide Compared to Lenalidomide/Low-dose Dexamethasone Combined With Single Cyclophosphamide Doses IV in Patients With Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial comparing lenalidomide plus low-dose dexamethasone with continuous oral cyclophosphamide versus lenalidomide/dexamethasone with sing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Cytoxan (cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)
• Revlimid (lenalidomide)

Snippet

Sponsor: Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED